Perioperative Opdivo Extends Event-Free Survival in Lung Cancer
Patients with resectable (surgically unremovable) non-small cell lung cancer (NSCLC) undergoing treatment with perioperative Opdivo (nivolumab) demonstrated extended event-free survival ...